The Use of Domperidone for Gastroparesis
The purpose of this study is to determine whether domperidone can be used safely and effectively for patient with gastroparesis.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Monitoring Study for the Use of Gastroparesis for Patient Who Have Failed Standard Therapy|
- Improved Gastric motility [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]Patients will have improved gastric motility within three months of begining domperidone therpy
|Study Start Date:||March 2010|
|Estimated Study Completion Date:||March 2014|
|Estimated Primary Completion Date:||March 2012 (Final data collection date for primary outcome measure)|
Patients to receive Domperidone for treatment of Gastroparesis
Patient to receive treatment with Domperidone
Other Name: Domperidone / Motilium
Individuals who have been diagnosed with gastroparesis and have failed at least one standard therapy will be offered to trial domperidone as a possible remedy to their condition. Patients on the medication will be expected to to be followed by the physician at 3 months, 6 months 12months, and then annually while on the medication. Any change or significant adverse reaction to the medication or in their condition should be reported immediately to their physician.